Anavex Life Sciences (AVXL) Competitors $8.52 +0.04 (+0.47%) (As of 11:15 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AVXL vs. BASI, VCEL, MOR, KYMR, SWTX, GMTX, ACAD, AMRX, ZLAB, and IOVAShould you be buying Anavex Life Sciences stock or one of its competitors? The main competitors of Anavex Life Sciences include Bioanalytical Systems (BASI), Vericel (VCEL), MorphoSys (MOR), Kymera Therapeutics (KYMR), SpringWorks Therapeutics (SWTX), Gemini Therapeutics (GMTX), ACADIA Pharmaceuticals (ACAD), Amneal Pharmaceuticals (AMRX), Zai Lab (ZLAB), and Iovance Biotherapeutics (IOVA). These companies are all part of the "medical" sector. Anavex Life Sciences vs. Bioanalytical Systems Vericel MorphoSys Kymera Therapeutics SpringWorks Therapeutics Gemini Therapeutics ACADIA Pharmaceuticals Amneal Pharmaceuticals Zai Lab Iovance Biotherapeutics Bioanalytical Systems (NASDAQ:BASI) and Anavex Life Sciences (NASDAQ:AVXL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations, valuation and community ranking. Which has stronger earnings & valuation, BASI or AVXL? Bioanalytical Systems has higher revenue and earnings than Anavex Life Sciences. Anavex Life Sciences is trading at a lower price-to-earnings ratio than Bioanalytical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioanalytical Systems$60.47M0.51-$4.68M-$0.35-7.97Anavex Life SciencesN/AN/A-$47.51M-$0.50-16.95 Do analysts recommend BASI or AVXL? Anavex Life Sciences has a consensus target price of $40.00, indicating a potential upside of 371.98%. Given Anavex Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Anavex Life Sciences is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Anavex Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is BASI or AVXL more profitable? Anavex Life Sciences has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. Anavex Life Sciences' return on equity of -30.64% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Bioanalytical Systems-7.75% -42.74% -6.38% Anavex Life Sciences N/A -30.64%-28.23% Does the MarketBeat Community favor BASI or AVXL? Anavex Life Sciences received 301 more outperform votes than Bioanalytical Systems when rated by MarketBeat users. Likewise, 74.35% of users gave Anavex Life Sciences an outperform vote while only 38.55% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformBioanalytical SystemsOutperform Votes12838.55% Underperform Votes20461.45% Anavex Life SciencesOutperform Votes42974.35% Underperform Votes14825.65% Do insiders & institutionals believe in BASI or AVXL? 10.6% of Bioanalytical Systems shares are held by institutional investors. Comparatively, 31.6% of Anavex Life Sciences shares are held by institutional investors. 11.5% of Bioanalytical Systems shares are held by company insiders. Comparatively, 11.0% of Anavex Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media refer more to BASI or AVXL? In the previous week, Anavex Life Sciences had 2 more articles in the media than Bioanalytical Systems. MarketBeat recorded 2 mentions for Anavex Life Sciences and 0 mentions for Bioanalytical Systems. Anavex Life Sciences' average media sentiment score of 0.56 beat Bioanalytical Systems' score of 0.00 indicating that Anavex Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Bioanalytical Systems Neutral Anavex Life Sciences Positive Which has more risk and volatility, BASI or AVXL? Bioanalytical Systems has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500. Comparatively, Anavex Life Sciences has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. SummaryAnavex Life Sciences beats Bioanalytical Systems on 11 of the 18 factors compared between the two stocks. Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVXL vs. The Competition Export to ExcelMetricAnavex Life SciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$718.68M$2.93B$5.01B$8.81BDividend YieldN/A1.89%5.16%4.06%P/E Ratio-16.9545.25134.3717.77Price / SalesN/A360.241,158.6875.18Price / CashN/A160.0933.5332.53Price / Book4.903.734.674.68Net Income-$47.51M-$41.63M$119.07M$226.08M7 Day Performance5.54%-4.73%-1.83%-1.04%1 Month Performance55.50%-6.53%-3.62%1.04%1 Year Performance26.12%25.63%31.63%26.28% Anavex Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVXLAnavex Life Sciences3.7059 of 5 stars$8.52+0.5%$40.00+369.5%+21.1%$722.50MN/A-17.0440Upcoming EarningsBASIBioanalytical SystemsN/A$3.21+15.1%N/A+22.9%$35.73M$60.47M-7.77397Analyst ForecastGap DownHigh Trading VolumeVCELVericel1.0997 of 5 stars$58.16+1.6%$58.140.0%+56.1%$2.87B$197.52M954.49300Analyst ForecastMORMorphoSys0.1344 of 5 stars$18.96flat$10.48-44.8%N/A$2.86B$238.28M-5.45730KYMRKymera Therapeutics1.4142 of 5 stars$43.56-1.1%$52.13+19.7%+110.9%$2.82B$78.59M0.00170Analyst ForecastSWTXSpringWorks Therapeutics2.0472 of 5 stars$36.55-2.4%$67.00+83.3%+68.5%$2.72B$5.45M0.00305Analyst ForecastGMTXGemini TherapeuticsN/A$62.55+5.0%N/A+14.7%$2.71BN/A-62.5530ACADACADIA Pharmaceuticals3.9104 of 5 stars$15.81-2.8%$25.56+61.7%-29.0%$2.63B$726.44M20.86510Insider TradeAnalyst RevisionAMRXAmneal Pharmaceuticals3.211 of 5 stars$8.34-0.8%$10.00+19.9%+86.9%$2.58B$2.39B0.007,700Insider TradeZLABZai Lab2.9675 of 5 stars$25.79-1.7%$52.50+103.6%-7.2%$2.57B$266.72M-9.472,175Analyst RevisionIOVAIovance Biotherapeutics4.0592 of 5 stars$8.29+1.8%$22.33+169.4%+48.3%$2.53B$1.19M0.00500Options Volume Related Companies and Tools Related Companies BASI Alternatives VCEL Alternatives MOR Alternatives KYMR Alternatives SWTX Alternatives GMTX Alternatives ACAD Alternatives AMRX Alternatives ZLAB Alternatives IOVA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AVXL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AVXL Stock Alerts